Zugriffe | |
---|---|
GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma | 134 |
August 2024 | September 2024 | Oktober 2024 | November 2024 | Dezember 2024 | Januar 2025 | Februar 2025 | |
---|---|---|---|---|---|---|---|
GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma | 3 | 4 | 3 | 5 | 1 | 1 | 1 |
Zugriffe | |
---|---|
2021_Zirngibl_etal.pdf | 195 |